Abstract
Matrix metalloproteinase 9 (MMP-9) is implicated in various physiological processes by its ability to degrade the extracellular matrix (ECM) and process multiple regulatory proteins. Normally, MMP-9 expression is tightly controlled in cells. Sustained or enhanced MMP-9 secretion, however, has been demonstrated to contribute to the pathophysiology of numerous diseases, including arthritis and tumor progression, rendering this enzyme a major target for clinical interventions. Here we show that constitutive MMP-9 secretion was abrogated in THP-1 monocytic leukemia cells by addition of neutralizing antibodies against tumor necrosis factor α (TNF-α) or TNF receptor type 1 (TNF-R1), as well as by inhibition of TNF-α converting enzyme (TACE). This indicates that MMP-9 production in these cells is maintained by autocrine stimulation, with TNF-α acting via TNF-R1. To investigate the intracellular signaling routes involved in MMP-9 gene transcription, cells were treated with different inhibitors of major mitogen-activated protein kinase (MAPK) pathways. Interruption of the extracellular signal-regulated kinase pathway 1/2 (ERK1/2) using PD98059 significantly downregulated constitutive MMP-9 release. In contrast, blockage of p38 kinase activity by addition of SB203580 or SB202190, as well as inhibition of c-Jun N-terminal kinase (JNK) using L-JNK-I1, clearly augmented MMP-9 expression and secretion by an upregulation of ERK1/2 phosphorylation. Moreover, exogenously added TNF-α augmented MMP-9 synthesis and secretion in THP-1 cells via enhancement of ERK1/2 activity. Taken together, our results indicate that ERK1/2 activity plays a pivotal role in TNF-α-induced MMP-9 production and demonstrate its negative modulation by p38 and JNK activity. These findings suggest ERK1/2 rather than p38 and JNK as a reasonable target to specifically block MMP-9 expression using MAPK inhibitors in therapeutic applications.
References
Arai, K., Lee, S.R., and Lo, E.H. (2003). Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes. Glia43, 254–264.10.1002/glia.10255Search in Google Scholar
Baud, V. and Karin, M. (2001). Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol.11, 372–377.10.1016/S0962-8924(01)02064-5Search in Google Scholar
Beck, G., Bottomley, G., Bradshaw, D., Brewster, M., Broadhurst, M., Devos, R., Hill, C., Johnson, W., Kim, H.J., Kirtland, S., et al. (2002). (E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2′-isobutyl-2′-(methanesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a selective and orally active inhibitor of tumor necrosis factor-α convertase. J. Pharmacol. Exp. Ther.302, 390–396.10.1124/jpet.302.1.390Search in Google Scholar
Bergers, G., Brekken, R., McMahon, G., Vu, T.H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., and Hanahan, D. (2000). Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol.2, 737–744.10.1038/35036374Search in Google Scholar
Black, R.A., Rauch, C.T., Kozlosky, C.J., Peschon, J.J., Slack, J.L., Wolfson, M.F., Castner, B.J., Stocking, K.L., Reddy, P., Srinivasan, S., et al. (1997). A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature385, 729–733.10.1038/385729a0Search in Google Scholar
Bogoyevitch, M.A., Boehm, I., Oakley, A., Ketterman, A.J., and Barr, R.K. (2004). Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential. Biochim. Biophys. Acta1697, 89–101.10.1016/j.bbapap.2003.11.016Search in Google Scholar
Chandler, S., Miller, K.M., Clements, J.M., Lury, J., Corkill, D., Anthony, D.C., Adams, S.E., and Gearing, A.J. (1997). Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. J. Neuroimmunol.72, 155–161.10.1016/S0165-5728(96)00179-8Search in Google Scholar
Coussens, L.M. and Werb, Z. (2002). Inflammation and cancer. Nature420, 860–867.10.1038/nature01322Search in Google Scholar
Coussens, L.M., Tinkle, C.L., Hanahan, D., and Werb, Z. (2000). MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell103, 481–490.10.1016/S0092-8674(00)00139-2Search in Google Scholar
Coussens, L.M., Fingleton, B., and Matrisian, L.M. (2002). Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science295, 2387–2392.10.1126/science.1067100Search in Google Scholar PubMed
Egeblad, M. and Werb, Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer2, 161–174.10.1038/nrc745Search in Google Scholar
Endo, H., Utani, A., and Shinkai, H. (2003). Activation of p38 MAPK suppresses matrix metalloproteinase-1 gene expression induced by platelet-derived growth factor. Arch. Dermatol. Res.294, 552–558.10.1007/s00403-002-0364-5Search in Google Scholar
Fiore, E., Fusco, C., Romero, P., and Stamenkovic, I. (2002). Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity. Oncogene21, 5213–5223.10.1038/sj.onc.1205684Search in Google Scholar
Genersch, E., Hayess, K., Neuenfeld, Y., and Haller, H. (2000). Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. J. Cell Sci.113, 4319–4330.10.1242/jcs.113.23.4319Search in Google Scholar
Giehl, K. (2005). Oncogenic Ras in tumour progression and metastasis. Biol. Chem.386, 193–205.10.1515/BC.2005.025Search in Google Scholar
Hamano, Y., Zeisberg, M., Sugimoto, H., Lively, J.C., Maeshima, Y., Yang, C., Hynes, R.O., Werb, Z., Sudhakar, A., and Kalluri, R. (2003). Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin. Cancer Cell3, 589–601.10.1016/S1535-6108(03)00133-8Search in Google Scholar
He, C. (1996). Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter. Cancer Lett.106, 185–191.10.1016/0304-3835(96)04318-2Search in Google Scholar
Hehlgans, T. and Mannel, D.N. (2002). The TNF-TNF receptor system. Biol. Chem.383, 1581–1585.Search in Google Scholar
Hilger, R.A., Scheulen, M.E., and Strumberg, D. (2002). The Ras-Raf-MEK-ERK pathway in the treatment of cancer. Onkologie25, 511–518.10.1159/000068621Search in Google Scholar
Holvoet, S., Vincent, C., Schmitt, D., and Serres, M. (2003). The inhibition of MAPK pathway is correlated with down-regulation of MMP-9 secretion induced by TNF-α in human keratinocytes. Exp. Cell Res.290, 108–119.10.1016/S0014-4827(03)00293-3Search in Google Scholar
Ismair, M.G., Ries, C., Lottspeich, F., Zang, C., Kolb, H.J., and Petrides, P.E. (1998). Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor-α (TNF-α) in NB4 leukemic cells: specific involvement of TNF receptor type 1. Leukemia12, 1136–1143.10.1038/sj.leu.2401042Search in Google Scholar PubMed
Kumar, S., Boehm, J., and Lee, J.C. (2003). p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat. Rev. Drug Discov.2, 717–726.10.1038/nrd1177Search in Google Scholar
Kyriakis, J.M. and Avruch, J. (2001). Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev.81, 807–869.10.1152/physrev.2001.81.2.807Search in Google Scholar
Lai, W.C., Zhou, M., Shankavaram, U., Peng, G., and Wahl, L.M. (2003). Differential regulation of lipopolysaccharide-induced monocyte matrix metalloproteinase (MMP)-1 and MMP-9 by p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J. Immunol.170, 6244–6249.10.4049/jimmunol.170.12.6244Search in Google Scholar
Lewis, T.S., Shapiro, P.S., and Ahn, N.G. (1998). Signal transduction through MAP kinase cascades. Adv. Cancer Res.74, 49–139.10.1016/S0065-230X(08)60765-4Search in Google Scholar
MacEwan, D.J. (2002). TNF receptor subtype signalling: differences and cellular consequences. Cell Signal.14, 477–492.10.1016/S0898-6568(01)00262-5Search in Google Scholar
McCawley, L.J. and Matrisian, L.M. (2001). Matrix metalloproteinases: they're not just for matrix anymore! Curr. Opin. Cell Biol.13, 534–540.10.1016/S0955-0674(00)00248-9Search in Google Scholar
Moll, U.M., Youngleib, G.L., Rosinski, K.B., and Quigley, J.P. (1990). Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res.50, 6162–6170.Search in Google Scholar
Moon, S.K., Cha, B.Y., and Kim, C.H. (2004). ERK1/2 mediates TNF-α-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-κB and AP-1: involvement of the ras-dependent pathway. J. Cell Physiol.198, 417–427.10.1002/jcp.10435Search in Google Scholar
New, L., Li, Y., Ge, B., Zhong, H., Mansbridge, J., Liu, K., and Han, J. (2001). SB203580 promotes EGF-stimulated early morphological differentiation in PC12 cell through activating ERK pathway. J. Cell Biochem.83, 585–596.10.1002/jcb.1253Search in Google Scholar
Numazawa, S., Watabe, M., Nishimura, S., Kurosawa, M., Izuno, M., and Yoshida, T. (2003). Regulation of ERK-mediated signal transduction by p38 MAP kinase in human monocytic THP-1 cells. J. Biochem. (Tokyo)133, 599–605.10.1093/jb/mvg077Search in Google Scholar
Opdenakker, G., Van den Steen, P.E., and Van Damme, J. (2001). Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol.22, 571–579.10.1016/S1471-4906(01)02023-3Search in Google Scholar
Overall, C.M. and Lopez-Otin, C. (2002). Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat. Rev. Cancer2, 657–672.10.1038/nrc884Search in Google Scholar
Pearson, G., Robinson, F., Beers, G.T., Xu, B.E., Karandikar, M., Berman, K., and Cobb, M.H. (2001). Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev.22, 153–183.Search in Google Scholar
Ramos-DeSimone, N., Hahn-Dantona, E., Sipley, J., Nagase, H., French, D.L., and Quigley, J.P. (1999). Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J. Biol. Chem.274, 13066–13076.10.1074/jbc.274.19.13066Search in Google Scholar
Rangaswami, H., Bulbule, A., and Kundu, G.C. (2005). JNK1 differentially regulates osteopontin-induced nuclear factor-inducing kinase/MEKK1-dependent activating protein-1-mediated promatrix metalloproteinase-9 activation. J. Biol. Chem.280, 19381–19392.10.1074/jbc.M414204200Search in Google Scholar
Rennefahrt, U., Janakiraman, M., Ollinger, R., and Troppmair, J. (2005). Stress kinase signaling in cancer: fact or fiction? Cancer Lett.217, 1–9.Search in Google Scholar
Ries, C. and Petrides, P.E. (1995). Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol. Chem. Hoppe-Seyler376, 345–355.Search in Google Scholar
Ries, C., Kolb, H., and Petrides, P.E. (1994). Regulation of 92-kDa gelatinase release in HL-60 leukemia cells: tumor necrosis factor-α as an autocrine stimulus for basal- and phorbol ester-induced secretion. Blood83, 3638–3646.10.1182/blood.V83.12.3638.3638Search in Google Scholar
Robinson, S., Scott, K., and Balkwill, F. (2002). Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-α. Eur. J. Immunol.32, 404–412.10.1002/1521-4141(200202)32:2<404::AID-IMMU404>3.0.CO;2-XSearch in Google Scholar
Sanceau, J., Boyd, D.D., Seiki, M., and Bauvois, B. (2002). Interferons inhibit TNFα-mediated MMP-9 activation via IRF1 binding competition with NF-κB. J. Biol. Chem.277, 35766–35775.10.1074/jbc.M202959200Search in Google Scholar
Schonbeck, U., Mach, F., and Libby, P. (1998). Generation of biologically active IL-1β by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1β processing. J. Immunol.161, 3340–3346.10.4049/jimmunol.161.7.3340Search in Google Scholar
Sebolt-Leopold, J.S. and Herrera, R. (2004). Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat. Rev. Cancer4, 937–947.10.1038/nrc1503Search in Google Scholar
Sternlicht, M.D. and Werb, Z. (2001). How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol.17, 463–516.10.1146/annurev.cellbio.17.1.463Search in Google Scholar
Stetler-Stevenson, W.G. (1990). Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev.9, 289–303.10.1007/BF00049520Search in Google Scholar
Stuelten, C.H., Byfield, S.D., Arany, P.R., Karpova, T.S., Stetler-Stevenson, W.G., and Roberts, A.B. (2005). Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-α and TGF-α. J. Cell Sci.118, 2143–2153.10.1242/jcs.02334Search in Google Scholar
Van den Steen, P.E., Proost, P., Wuyts, A., Van Damme, J., and Opdenakker, G. (2000). Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-α and leaves RANTES and MCP-2 intact. Blood96, 2673–2681.10.1182/blood.V96.8.2673Search in Google Scholar
Vincenti, M.P. and Brinckerhoff, C.E. (2002). Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res.4, 157–164.10.1186/ar401Search in Google Scholar PubMed PubMed Central
Waetzig, G.H., Seegert, D., Rosenstiel, P., Nikolaus, S., and Schreiber, S. (2002). p38 mitogen-activated protein kinase is activated and linked to TNF-α signaling in inflammatory bowel disease. J. Immunol.168, 5342–5351.10.4049/jimmunol.168.10.5342Search in Google Scholar PubMed
Westermarck, J. and Kahari, V.M. (1999). Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J.13, 781–792.10.1096/fasebj.13.8.781Search in Google Scholar
Yu, Q. and Stamenkovic, I. (2000). Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-α and promotes tumor invasion and angiogenesis. Genes Dev.14, 163–176.10.1101/gad.14.2.163Search in Google Scholar
©2006 by Walter de Gruyter Berlin New York
